Ved Mediserve Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.01 M
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.80 M
- Revenue Growth 32.16%
- Profit Growth 65.74%
- Ebitda 61.51%
- Net Worth -1.83%
- Total Assets -1.93%
About Ved Mediserve
Ved Mediserve Private Limited (VMPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 1995 and has a history of 29 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.01 M.
The company currently has active open charges totaling ₹7.80 M.
Poonam Monga and Sunil Monga serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1995PTC070663
-
Company No.
070663
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jul 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ved Mediserve?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Monga
|
Director | 10-Jul-1995 | Current |
|
Poonam Monga
|
Director | 29-Sep-2015 | Current |
Financial Performance of Ved Mediserve.
Ved Mediserve Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 32.16% increase. The company also saw a substantial improvement in profitability, with a 65.74% increase in profit. The company's net worth dipped by a decrease of 1.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ved Mediserve?
In 2019, Ved Mediserve had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Purushottam Financiers LlpPoonam Monga and Sunil Monga are mutual person
-
Mediserve Devices Private Limited
Poonam Monga is a mutual person
Charges (Loans)
₹7.80 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.58 Cr
- The Catholic Syrian Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2007 | State Bank Of India | ₹5.80 M | Open |
| 31 Oct 2003 | The Catholic Syrian Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Ved Mediserve?
Unlock and access historical data on people associated with Ved Mediserve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ved Mediserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ved Mediserve's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
